INTRODUCTION
The androgen receptor (AR) is a transcription-regulating protein that plays a pivotal role in the programming of male sexual differentiation and development. Absence or mutation of the X-chromosome-located AR gene can lead to complete androgen-insensitivity, and the affected 46,XY individual displays the external phenotype of a female [1] [2] [3] [4] [5] [6] [7] . Mutations in AR are also thought to be involved in less severe forms of aberrant male sexual development.
Structurally and functionally AR belongs to the superfamily of ligand-responsive transcription modifiers which encompasses the receptors for the steroid and thyroid hormones, retinoic acid, vitamin D3 and several 'orphan' receptors for which a ligand has not as yet been identified [8] [9] [10] [11] . The structural regions that these receptors have in common, namely a C-terminal ligand-binding domain, an internal DNA-binding domain, consisting of two Cys-Cys zinc finger motifs and an N-terminal hypervariable ' regulatory' domain, enable them to react to a hormonal stimulus by modulation of gene transcription through recognition of, and binding to, hormone-responsive elements (HREs) located in the control regions of target genes.
The isolation of human AR (hAR) and rat AR (rAR) cDNAs [12] [13] [14] [15] [16] [17] and the elucidation of the structural organization of the hAR gene [18-20a] has provided important tools to address questions regarding AR function in the androgen signal-transduction pathway. In common with the glucocorticoid receptor and the progesterone receptor, the androgen receptor is able to regulate expression of a mouse-mammary-tumour-virus longterminal-repeat (MMTV LTR)-driven promoter, although perhaps less efficiently [21] [22] [23] . This indicates that the DNA motif recognized by the AR is identical with, or closely related to, the GRE and PRE consensus sequence GGTACAnnnTGTTCT. In order to extend findings to different species, it is necessary to isolate species-specific tools. Especially for detailed studies in vivo concerning molecular and genetic mechanisms of AR synthesis and function, including transgenic animals, and study of the physiological effects of manipulation of the AR system, knowledge of the mouse AR (mAR) system is ofhigh importance.
In the present study we describe the characterization of the mAR gene and cDNA. A mAR expression vector (pmARO) was constructed and applied for the functional characterization of the mAR protein. In addition, the promoter of the mAR gene is structurally and functionally characterized.
MATERIALS AND METHODS

Isolation and characterization of mAR genomic DNA clones
A mouse genomic DNA library in lambda EMBL3 SP6/T7 was purchased from Clontech (Palo Alto, CA, U.S.A.). The library was plated, transferred to nitrocellulose filters (Schleicher and Schiill, Dassel, Germany) and hybridized to 32P-labelled hAR cDNA probes (see Fig. 2a below), according to standard procedures [24, 25] . Positive phages were isolated by three rounds of purification. All experiments concerning the isolation, subcloning and characterization of phage DNA inserts by restriction mapping and Southern-blot hybridization were performed P. W. according to standard procedures [24, 25] . Sequence analysis was done by the dideoxy-chain-termination method on both DNA strands using single-stranded M13mpl8/19 DNA preparations [26] and T7 polymerase (Pharmacia, Uppsala, Sweden).
RNA preparation and Sl-nuclease-protection experiments Total cellular RNA was isolated by the guanidinium thiocyanate method [27] . For the SI-nuclease-protection assay a 0.6 kb EcoRI-HindIll double-stranded DNA fragment (see Fig.  5a below) was used as a probe. The fragment was end-labelled using T4 polynucleotide kinase (Gibco BRL, Grand Island, NY, U.S.A.), and approx. 1 x 105 c.p.m. of probe were annealed to 40 jug of RNA in 80 % formamide/40 mM-Pipes (pH 6.5)/0.4 MNaCl/l mM-EDTA overnight at 55°C [28] . SI-nuclease (Boehringer, Mannheim, Germany) digestions were carried out for 1 h at 37 'C, and the resulting protected fragments were analysed on a denaturing 6 % (w/v) polyacrylamide gel.
DNA amplification
Oligonucleotides were synthesized on an Applied Biosystems 381A DNA synthesizer. Amplification by the PCR [29] was performed in 100 1ld reaction mixtures containing 2 % of a firststrand cDNA preparation, using 2 units of Taq DNA polymerase (Promega, Madison, WI, U.S.A.) under the conditions described by the manufacturer. For first-strand cDNA preparations, 100 ng of the appropriate primer was annealed to 5/,tg of total RNA, and cDNA synthesis was performed with avian-myeloblastosisvirus reverse transcriptase according to a standard protocol (Promega). Amplification was performed in a Bioexcellence DNA incubator for 30 cycles. Standard conditions were: denaturation for 1 min at 95°C, annealing for 2 min at 60°C and extension for 1-5 min at 70 'C. The amplification products were recovered after chloroform/3-methylbutan-1 -ol extraction, electrophoresed through 1-1.5 %-(w/v)-agarose gels and blotted on nitrocellulose filters for hybridization. For isolation and subcloning, the fragments were extracted with phenol/chloroform and ethanolprecipitated. The oligonucleotides used (see The 0.5 kb PstI-HindIII and the 1.3 kb PstI-PstI genomic DNA fragments were isolated from a subcloned 1.5 kb EcoRI-EcoRI fragment (see Fig. 5a below). The PstI-PstI fragment was cloned in both orientations in the PstI site of the multiple cloning site (MCS) of the promoterless pCAT-Enhancer plasmid (Promega; referred to as 'pmAR-CAT-0'). This resulted in the construction of pmAR-CAT-1 and pmAR-CAT-1 rev (reverse) respectively. The 0.5 kb Pstl-HindIII (blunt-ended) fragment was cloned in a PstI-AccI (blunt-ended) pCATEnhancer vector, and in pCAT-Enhancer (PstI-HindIII), resulting in the construction of pmAR-CAT-2 and pmAR-CAT-2 rev, which contain the fragment in the normal and reverse orientation respectively.
Construction of the mAR expression plasmid pmARO
Using genomic DNA fragments, and cDNA fragments obtained by PCR amplification a mAR expression plasmid, containing the complete mAR ORF, was constructed. A partial restriction map of the mAR cDNA, together with the three fragments from which it was derived, is presented in Fig. 1 .
Fragment A (EcoRI-NcoI) was derived from the 2 kb EcoRI-EcoRI genomic DNA fragment that contains the proteincoding region ofexon 1 (see Fig. Sa below) , whereas the fragments B (NcoI-HindIII) and C [HindIII-3'-untranslated region (UTR)] originated from reverse-transcriptase PCR using a first-strand cDNA preparation made with primer arml (Fig. 3 below) and mouse testis RNA. The fragments were produced by PCR with the primer combinations armI and arm3 (C) and arm2 and arm4 (B) respectively. The cDNA construct was prepared in a pGEM vector and completely sequenced. A mAR expression vector was constructed using the cDNA containing the complete mAR ORF, the simian-virus-40 (SV40) early promoter and the rabbit /J-globin polyadenylation signal [21] . The resulting vector is referred to as 'pmARO'. [18, 20a] . In Fig. 2 (a) the hAR cDNA is schematically depicted, together with the cDNA probes used and the distribution of the hAR cDNA sequence over the exons of the hAR gene. The probes cover the complete protein-coding regions of the hAR gene exons 1-8. Screening of the mouse genomic DNA library resulted in the isolation of eight clones (Fig. 2b) . Probes A and B hybridized to clone 5'mAR; clones 15A and 19A were both recognized by probes B and C; probe C hybridized to clones 15B and 18A; clones 6B and 3A could be identified by probes C, D and E; probes D, E and F recognized clone IA. A physical map of the mAR gene was constructed on the basis of restriction-enzyme-digestion patterns combined with sequence analysis of the individual exons (see Fig. 2b ). For this sequence analysis, mouse genomic DNA fragments hybridizing with hAR cDNA probes were subcloned in plasmid vectors and mapped in more detail. Small fragments containing the exons were subsequently cloned in M 13 vectors and sequenced. Fig. 2(b) shows the positions of the eight mAR exons and the restriction map for BamHI, EcoRI, HindIII and XhoI. The sequence obtained is presented in Fig. 3 and is discussed in detail below. Additional hybridization experiments using probes specific for the promoter region of the hAR gene and the polyadenylation sites of the hAR mRNA indicated their presence in clones 5'mAR and IA, respectively, and they are depicted as such in Fig. 2(b) .
The eight overlapping clones cover a 60 kb region of genomic DNA. Although all the exons of the mAR gene are present in the clones isolated, part of the information for the introns 1, 2 and 3 is lacking. The lengths of the introns as deduced from these clones are > 14.5 kb (intron 1), > 19.1 kb (2), > 12.4 kb (3), 5.2 kb (4), 4.1 kb (5), 1 .0 kb (6) and 0.7 kb (7) respectively. The physical map of the mAR gene was checked by Southern-blot analysis of mouse genomic DNA digested with the restriction enzymes BamHI, EcoRI and HindIlI. Blots were probed with genomic probes spanning all exons of the mAR gene. These experiments confirmed the restriction map presented in Fig. 2(b) (results not shown). In addition, the sizes of the various hybridizing fragments detected in these genomic blots indicated that the length of intron 3 exceeds 20 kb. This finding extends the minimum length of the mAR gene to at least 68 kb.
Sequence analysis of the mAR open reading frame (ORF)
As discussed above, small fragments containing exon information were sequenced to predict the structure of the mAR cDNA ORF. Protein-coding sequences as well as intron/exon boundaries were deduced on the basis of similarity to the hAR ORF and splice consensus sequences respectively. This resulted in a predicted ORF for the mAR cDNA shown in Fig. 3 , together with the sequences of the intron/exon boundaries, which all conform to the GT/AG rule (doubly underlined in Fig. 3 Functional analysis of mAR expressed from the molecular cloned cDNA A mAR cDNA containing the complete ORF was constructed using conventional cloning methods combined with the PCR techniques described in the Materials and methods section. After insertion of the mAR cDNA in a pGEM vector, the 2.8 kb insert was completely sequenced and the sequence was matched with that of the deduced mAR genomic DNA structure. The sequence showed the mAR ORF to be identical with the predicted ORF as already presented in Fig. 3, and thereby confirmed (pmARO; Fig. 4a ). mAR was transiently expressed in COS-l cells. To determine the size of the protein produced, Westernblot analysis was performed after immunoprecipitation of mAR from whole-cell extracts using an AR-specific monoclonal antibody. The blot was probed with an anti-AR polyclonal antibody. Controls included cell extracts prepared from mock-transfected COS-1 cells, COS-I cells transfected with the hAR expression plasmid pARO, cell extracts prepared from mouse testicular tissue and immunoprecipitations with a non-specific monoclonal antibody. The results of these experiments are shown in Fig. 4(b Fig. 4(a) The autoradiograph of the t.l.c. analyses of the CAT assays is depicted in Fig. 4(c) . The control experiments show that the synthetic androgen R1881 has no effect on CAT expression from the pG 29 G-TK-CAT reporter gene in the absence of the mAR (compare lanes 1 and 2) . Similarly, in the presence of ligand, mAR has no stimulating effect on the TK promoter (compare lanes 3 and 4). In lanes 7 and 8 the activity of pSV2-CAT is illustrated, which, as expected, is not influenced by R1881. Cotransfection of pmARO and pG 29 G-TK-CAT shows a liganddependent increase in CAT-activity (compare lanes 5 and 6). These experiments prove that mAR is able to trans-activate an androgen-responsive promoter through the appropriate response elements. Quantification of the CAT assay resulted in the calculation of an induction factor of 30 (results not shown).
Determination of the transcriptional start sites and polyadenylation sites of the mAR gene Hybridization studies using hAR probes spanning the transcription initiation sites of the hAR gene identified a region of sequence similarity in clone 5'mAR (Fig. 2b) . In Fig. 5(a) a restriction map of the region surrounding the first exon of the mAR gene is shown. The ATG translation-initiation codon as well as the splice donor site at the exon /intron 1 boundary (GTAAG) are indicated. To determine whether the region upstream from the ATG codon contained promoter activity, a CAT reporter-gene construct containing SV40 enhancer sequences, but lacking transcription-initiation sites was used. Four CAT expression plasmids with mAR gene-promoter fragments were constructed (Fig. 5b) . The Specific protected fragments were absent in the control experiment (lane 2), whereas, in the case of mouse prostatic RNA (lane 3) and pmAR-CAT-l transfected COS-1 RNA (lane 4), two sets of protected fragments were observed. The sequence of the region surrounding the transcription-initiation sites was determined (Fig. 6 ). The positions of the transcription-initiation sites is indicated with dots, and the most 5' nucleotide of the two sets of transcription initiation sites is numbered + 1. The promoter region of the mAR gene lacks the canonical TATA/ CCAAT elements which are found at 20-30 bp and 70-100 bp upstream from the transcription start sites ofmany genes. Neither is the promoter of the mAR gene exceptionally (G+ C)-rich, as is often observed in TATA/CCAAT minus promoters. Potential promoter elements which are present in the mAR gene promoter are a consensus Spl binding site at positions -36 to -45 (underlined) and a homopurine stretch at positions -55 to -125 (doubly underlined). Because clone IA (Fig. 2b) hybridized to a hAR cDNA probe located at the very 3' end of the cDNA, additional hAR cDNA probes spanning the complete 6.8 kb 3'-UTR were hybridized to subcloned fragments from clone IA. All probes gave rise to hybridization signals, but the probe spanning the polyadenylation signals of hAR mRNA produced the most intense signal (results not shown). These results suggested a moderate conservation for most of the 3'-UTR sequences and a more pronounced conservation for the sequences surrounding the polyadenylation sites. The fragment from clone IA, which hybridizes to the 3'-terminus of hAR cDNA, was sequenced, and this sequence was matched with the corresponding hAR sequence (Fig. 7) . The hAR DNA sequence extends from 10315 to 10625 from the transcription start site (cDNA), followed by a small stretch of 3'-flanking genomic sequences [20a] ; the corresponding mouse sequence is numbered 1-359. The polyadenylation signals that were functionally identified in the hAR mRNA (ATTAAA and CATAAA) are boxed. the actual sites of poly(A) addition in the hAR mRNA are indicated by dots, and the TG boxes, usually found in the immediate downstream region of polyadenylation sites, are doubly underlined for both the human and mouse sequence.
fragments, a 0.5 kb PstI-HindIII fragment and a 1.3 kb PstI-PstI fragment were cloned in front of the CAT gene in both sense and anti-sense orientation, giving rise to the constructs pmAR-CAT-1 and pmAR-CAT-1 rev in the case of the 1.3 kb PstI-PstI fragment and pmAR-CAT-2 and pmAR-CAT-2 rev in the case of the 0.5 kb PstI-HindIII fragment. All constructs were transfected into HeLa cells, together with the internal control plasmid pCHl 10, and 48 h after transfection cell extracts were assayed for CAT activity. Values obtained were normalized for fl-galactosidase activity and the activity of the pmAR-CAT-0 plasmid was arbitrarily set to 1. The results of the experiments are given as relative CAT activities in Fig. 5(b) and show that the insertion of the two mAR gene fragments in the proper orientation produces a marked increase in CAT activity, whereas the insertion of the same fragments in the reverse orientation slightly reduces basal activity. Because pmAR-CAT-2 is active, the promoter of the mAR gene has to be located in this region. The Fig. 5(c) .
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DISCUSSION
In the present study the structural organization of the mAR gene is described. In addition, the mAR protein is functionally characterized. The mAR gene was shown to consist of eight exons. From the genomic clones an ORF of 2697 nucleotides was deduced that encodes a 899-amino-acid protein. This sequence was verified by the isolation of mAR cDNA using conventional cloning techniques coupled with PCR amplification.
The 899-amino-acid protein contains the domains (N-terminal 'regulatory', DNA-binding and ligand-binding) characteristic of the receptor family. Fig. 8 shows a schematic comparison of the sequence similarity between the mAR, the hAR and the rAR [12] [13] [14] [15] [16] [17] . Total (100 %) identity is observed in the DNA-binding and ligand-binding domains. In the N-terminal 'regulatory' domain, some (minor) differences were observed, resulting in 76 and 96% similarity for the hAR and rAR in these domains respectively. The overall similarity was 85 % for the hAR and 98 % for the rAR. Also indicated in Fig. 8 are the homopolymeric stretches of glutamine and glycine residues. As to the position within the protein, the mAR stretches resemble those of the rAR, but the composition of the glutamine stretch is different, because it is shorter by two amino acids and intermingled with three histidine residues (Gln5-His-Gln3-His-Gln2-His-Gln4).
Co-transfections of pmARO with the androgen-responsive CAT reporter gene construct pG 29 activation has been made in the transcription factor SPI [38] . Interestingly, the recently cloned human TFIID transcription factor also contains a long polyglutamine stretch [39] [40] [41] .
During the preparation of this manuscript the sequence of the mAR cDNA was reported by others [42, 43] . Comparison of these cDNA sequences with the mAR sequence presented here showed the three sequences to be completely identical. The information of the mAR cDNA is separated over exons 1-8 of the mAR gene in a manner identical with that found in the hAR gene [18-20a] . When compared with the hAR gene the lengths of the individual introns are roughly conserved between the two species ( Table 1) . The introns 1, 2 and 3 are large (part of the information for the introns 1 and 2 is missing for both genes, whereas intron 3 is 26 kb in the human gene and at least 20 kb in the mouse gene). The lengths of the introns 4-7 could be determined for both genes and were found to be highly comparable.
A similar genomic organization with conserved intron/exon boundaries has been reported for the chicken progesterone receptor (cPR) [44, 45] and human oestrogen receptor (hER) [46] genes. The positions of the intron/exon boundaries are less well conserved in genes encoding more distant members of the receptor family, such as the human vitamin D3 receptor [47] and the chicken thyroid-hormone receptor [48] , indicating an early divergence during evolution between the steroid receptors and other receptors of the same family. The lengths of the introns 4 of the cPR and hER genes are unrelated to those observed in the mAR and hAR gene, with those of the cPR being substantially smaller and those of the hER gene being substantially larger. Two major sites of transcription initiation were identified in a 13 bp region. These transcription-initiation sites could be defined using RNA preparations originating either from mouse prostatic tissue or from COS-1 cells transfected with mAR promoter-CAT constructs. Both promoter constructs (pmAR-CAT-1 and pmAR-CAT-2), which differed only by the length of the 5'-UTR, conferred promoter activity to a promoterless CAT reporter gene. The activity of pmAR-CAT-l, which contains an approx. 0.8 kb longer 5'-UTR than pmAR-CAT-2, was slightly higher. A similar effect has been noted using hAR promoter constructs [20a] , suggesting a potentiating role of 5'-UTR sequences in transcriptional -activation, an increased stability of the RNA produced or an increase in translation efficiency caused by the presence of the longer 5'-UTR.
Putative promoter elements are the consensus Sp 1 binding site (GGGGCGGGAC, -36 to -45) and the homopurine stretch (-55 to -125). Spl is an ubiquitous transcription factor with DNA binding sites usually clustered in the promoter region of (G + C)-rich promoters, whereas homopurine stretches with various compositions have been identified in the promoter region of several genes [49] . These stretches are usually associated with a high sensitivity in vitro to SI-nuclease degradation and an unusual DNA structure [50] . Whether in the cell nucleus polypurine stretches are correlated with unfolding of the DNA is not known. Deletion of a polypurine/pyrimidine stretch in the promoter region of the epidermal-growth-factor-receptor gene resulted in a 3-fold decrease in promoter activity [51] . Analysis of this fragment by protein-DNA interaction experiments showed specific binding of two proteins, one of which turned out to be Sp . A similar analysis of the promoter of the mouse Ki-ras gene also indicated the homopurine stretch to be involved in transcriptional activation and specific protein-DNA interactions [52] .
Recently, we and others identified the promoter region of the hAR and rAR gene [20,20a,53] . A schematic comparison of the promoter regions of the three genes is given in Fig. 9 . The positions of the transcription-initiation sites are identical in the three genes. The putative Spl-binding site and the homopurine stretch are also conserved. The homopurine stretch can be divided in a 5'-fragment, consisting mainly of a multimer of the sequence motif GGGGA, and a 3'-fragment, without repeat elements. The 5'-segments of the homopurine stretch contains six, eight and four (GGGGA) blocks in the case of the mAR, rAR and hAR gene promoters respectively. More-upstream regions are moderately well conserved; the 5'-UTR shows high sequence similarity (see Fig. 9 ). A more detailed functional analysis will have to be conducted to evaluate the importance of the various structural elements in the AR promoter region.
The 3'-UTR of the mAR mRNA has a length of approx. 6 kb. This length is inferred from the identification of two potential polyadenylation signals in the mAR gene sequence (ATTAAA and CATAAA) at exactly the same position, where the functional polyadenylation signals of the hAR are situated [20a] . The two signal sequences differ from the canonical AATAAA hexamer sequence, but have previously been implicated in polyadenylation processes [54] . Although not strictly proven, the remarkable conservation between the hAR and mAR sequences in this region indicates that the same signals will be used for polyadenylation in the hAR and mAR transcripts. In addition, the strong sequence similarity suggests that the complete region is of high importance for polyadenylation or other, so-far-unidentified, functions of the AR gene or mRNA. The mRNA which would be produced from the complete mAR transcription unit would have a length of approx. 10 kb {l kb [5 [42, 43, 55] .
In summary, we have defined the transcription unit of the mAR gene and functionally characterized the mAR protein product that originates from this gene. The information obtained provides the opportunity for a detailed analysis of regulation of expression of the mAR gene and mAR function in 'in vivo' model systems. The sequence similarity between the mAR and hAR proteins and the promoter region of the mAR and hAR genes suggests a functional interchangeability for the individual protein domains as well as the regulatory regions of the promoters. A particularly interesting possibility would be either the correction of the naturally occurring mutation in the AR of the Tfm mouse [56] or the introduction of mutations, observed in the hAR in individuals with an aberrant male sexual development, in the mAR gene by homologous recombination techniques [57] to prove that these indeed correlate with the observed phenotypes. The information obtained from such experiments would be of great value for understanding of the role of AR in normal and abnormal male sexual development.
